Home/Investors/BlackRock

BlackRock

Biotech Investor · 4 portfolio companies

Portfolio

4

Combined Value

$675.4B

Focus Areas

16

Top Stage

Commercial

Investment Focus

Oncology Immunology Neuroscience Infectious Diseases Cardiovascular Metabolism Respiratory HIV Vaccines Hematology Genetic Disorders Metabolic Diseases Liver Diseases Genetic Diseases Autoimmune Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Johnson & Johnson	Commercial	$567.2B	Oncology, Immunology
GSK plc	Commercial	$104.1B	Respiratory, HIV
Beam Therapeutics	Phase 1/2	$2.5B	Hematology, Oncology
Intellia Therapeutics	Phase 3	$1.5B	Genetic Diseases, Oncology

Frequent Co-Investors

Public shareholders2 shared Institutional investors2 shared Vanguard2 shared Fidelity Management & Research Company2 shared Vanguard Group1 shared State Street1 shared Atlas Venture1 shared Arch Venture Partners1 shared